107 phenotypes from 5 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd	abnormal bone structure	J:211773
	abnormal brain morphology	J:211773
	abnormal heart morphology	J:211773
	abnormal liver morphology	J:211773
	abnormal skin morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased brain size	J:211773
	decreased circulating triglyceride level	J:211773
	decreased fasting circulating glucose level	J:211773
	enlarged heart	J:211773
	enlarged liver	J:211773
	enlarged spleen	J:211773
	eye hemorrhage	J:211773
	increased heart weight	J:211773
Cd36obl/Cd36obl C57BL/6-Cd36obl	abnormal cell-mediated immunity	J:96018
	abnormal macrophage physiology	J:96018
	abnormal olfaction	J:236910
	endophthalmitis	J:96018
	increased susceptibility to bacterial infection	J:96018
	increased susceptibility to induced morbidity/mortality	J:96018
	ocular pterygium	J:96018
Cd36tm1Frm/Cd36tm1Frm B6.129S4-Cd36tm1Frm	abnormal kidney morphology	J:100140
	abnormal pericardium morphology	J:100140
	abnormal response to infection	J:100140
	decreased interleukin-6 secretion	J:100140
	decreased interleukin-12 secretion	J:100140
	decreased tumor necrosis factor secretion	J:100140
	impaired macrophage phagocytosis	J:100140
	increased susceptibility to bacterial infection induced morbidity/mortality	J:100140
	sepsis	J:100140
Cd36tm1Frm/Cd36tm1Frm involves: 129S4/SvJae	abnormal microglial cell physiology	J:140907
Cd36tm1Frm/Cd36tm1Frm involves: 129S4/SvJae * C57BL/6J	abnormal chemokine level	J:80658
	abnormal macrophage physiology	J:80658
Cd36tm1Mfe/Cd36tm1Mfe B6.129S1-Cd36tm1Mfe	abnormal B cell morphology	J:130897
	abnormal choriocapillaris morphology	J:281382
	abnormal circulating lipid level	J:87372
	abnormal exocrine pancreas physiology	J:102503
	abnormal fatty acids level	J:87372
	abnormal food intake	J:87372
	abnormal food preference	J:102503
	abnormal gluconeogenesis	J:87372
	abnormal glucose homeostasis	J:87372
	abnormal lipid level	J:87372
	abnormal liver physiology	J:135594
	abnormal plasma cell differentiation	J:130897
	abnormal retina photoreceptor morphology	J:281382
	decreased body weight	J:87372
	decreased fatty acids level	J:87372
	decreased IgG1 level	J:130897
	decreased IgG2a level	J:130897
	decreased IgG2c level	J:130897
	decreased IgG level	J:130897
	decreased IgM level	J:130897
	decreased immunoglobulin level	J:130897
	decreased liver free fatty acids level	J:135594
	decreased liver triglyceride level	J:135594
	decreased susceptibility to induced thrombosis	J:136325
	disorganized photoreceptor outer segment	J:281382
	disorganized retina outer nuclear layer	J:281382
	increased circulating free fatty acids level	J:87372
	increased circulating ketone body level	J:87372
	increased circulating triglyceride level	J:87372
	increased fatty acids level	J:87372
	increased liver triglyceride level	J:87372
	increased transitional stage B cell number	J:130897
	thin retina outer nuclear layer	J:281382
Cd36tm1Mfe/Cd36tm1Mfe involves: 129S1/Sv	abnormal blood pressure regulation	J:109739
	abnormal brown adipose tissue physiology	J:220343
	abnormal macrophage chemotaxis	J:89664
	abnormal muscle physiology	J:220343
	abnormal myelination	J:89664
	abnormal peripheral nervous system regeneration	J:89664
	abnormal triglyceride level	J:220343
	decreased adipocyte glucose uptake	J:220343
	decreased brown adipose tissue amount	J:220343
	decreased circulating glucose level	J:220343
	decreased circulating triglyceride level	J:220343
	decreased muscle cell glucose uptake	J:220343
	decreased skeletal muscle glycogen level	J:220343
	normal homeostasis/metabolism phenotype	J:220343
	impaired adaptive thermogenesis	J:220343
Cd36tm1Mfe/Cd36tm1Mfe involves: 129S1/Sv * C57BL/6	abnormal basal metabolism	J:126461
	abnormal cardiovascular system physiology	J:83611, J:112746
	abnormal cholesterol homeostasis	J:56081
	abnormal fat pad morphology	J:126461
	abnormal food intake	J:126461
	abnormal homeostasis	J:123605
	abnormal hormone level	J:126461
	abnormal intestinal absorption	J:123605
	abnormal intestinal lipid absorption	J:123605
	abnormal lipid homeostasis	J:56081
	abnormal response to cardiac infarction	J:83611, J:112746
	abnormal small intestine morphology	J:123605
	abnormal triglyceride level	J:123605
	cardiac hypertrophy	J:83611
	decreased body size	J:123605, J:126461
	decreased bone mass	J:126461
	decreased cardiac muscle glycogen level	J:83611
	decreased cardiac muscle triglyceride level	J:83611
	decreased circulating adiponectin level	J:126461
	decreased fasting circulating glucose level	J:56081
	decreased intestinal cholesterol absorption	J:123605
	decreased percent body fat/body weight	J:126461
	normal homeostasis/metabolism phenotype	J:123605
	increased cardiac muscle cell glucose uptake	J:83611
	increased circulating cholesterol level	J:56081
	increased circulating HDL cholesterol level	J:56081
	increased circulating ketone body level	J:126461
	increased circulating leptin level	J:126461
	increased circulating triglyceride level	J:56081
	increased circulating VLDL triglyceride level	J:56081
	increased fatty acids level	J:56081
	increased intestinal glucose absorption	J:123605
	slow postnatal weight gain	J:126461
Cd36tm2.1Mfe/Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk	abnormal glucose homeostasis	J:225392
	abnormal response to cardiac infarction	J:225392
	normal cardiovascular system phenotype	J:225392
	decreased cardiac muscle triglyceride level	J:225392
	decreased fatty acid oxidation	J:225392
	decreased fatty acids level	J:225392